This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Expression of Oncogenic Human Papillomavirus E6/E7 Protein in Tampon Self-Tests

This study has been completed.
Information provided by:
University of Aarhus Identifier:
First received: September 6, 2007
Last updated: August 12, 2008
Last verified: August 2008

The purpose of this study is to examine for HPV E6/E7 mRNA in tampon self-tests, and compare with the cytological and histological diagnoses.

Study Hypothesis: Expression of HPV E6/E7 mRNA in Tampon self-tests are a suitable alternative to the routine cervical smear.

Condition Phase
Normal Uterine Cervical Cytology Uterine Cervical Dysplasia Uterine Cervical Neoplasms Early Phase 1

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: Expression of Oncogenic Human Papillomavirus E6/E7 Protein in Tampon Self-Tests

Resource links provided by NLM:

Further study details as provided by University of Aarhus:

Primary Outcome Measures:
  • Sensitivity and specificity of the HPV test of the material from the tampon self-test [ Time Frame: Spring 2008 ]

Biospecimen Retention:   Samples With DNA
Tampon self-test from cervix

Enrollment: 72
Study Start Date: August 2007
Study Completion Date: July 2008
Primary Completion Date: February 2008 (Final data collection date for primary outcome measure)
Women with at least moderate dysplasia in biopsies from cervix uteri
Women with only normal PAP-smears


Ages Eligible for Study:   23 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
50 women in out-patient gynecological ward in account of cervical cell changes and 50 women in the national screening program for cervical cancer, included by their G.P.

Inclusion Criteria:

  • Women with cervical dysplasia been referred to conisation.
  • Women invited to cervical screening program and with only normal smear and normal smears in their history.

Exclusion Criteria:

  • Women not performing the tampon self-test before conisation.
  • Women not performing the tampon self-test at least 3 month after having a normal PAP-smear taken.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00526370

Region Hospital Randers
Randers, Denmark, 8900
Sponsors and Collaborators
University of Aarhus
Study Director: Hans Svanholm, Head of department Region Hospital, Department of Pathology
  More Information

Responsible Party: Else Toft Würtz, Student Identifier: NCT00526370     History of Changes
Other Study ID Numbers: TP07-2351
Study First Received: September 6, 2007
Last Updated: August 12, 2008

Keywords provided by University of Aarhus:
self test
PAP smear
tampon test

Additional relevant MeSH terms:
Uterine Cervical Dysplasia
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
Precancerous Conditions
Uterine Cervical Diseases
Uterine Diseases
Genital Diseases, Female
Carcinoma in Situ
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Uterine Neoplasms
Genital Neoplasms, Female
Urogenital Neoplasms
Neoplasms by Site processed this record on August 18, 2017